Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients

Transplantation Proceedings

Volumn 35, Issue 2, 2003, Pages 700-

  Fernández Fresnedo, Gema ^a   Escallada, R ^a   De Francisco, A L M ^a   Rodrigo, E ^a   Zubimendi, J A ^a   Ruiz, J C ^a   Pinera C ^a   Herraez, I ^a   Arias, M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; PATIENT; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; SURVIVAL; TRANSPLANTATION; VASCULAR DISEASE;

EID: 0037339182     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00052-6     Document Type: Conference Paper

References (3)

1. Reisater A.V., Hartmann A. Transplant Proc. 33:2001;s8.
2. Adler A.I., Boyko E.J., Ahroni J.H., et al. Diab Care. 20:1997;1162.
3. Marchetti P. Transplant Proc. 33:2001;s27.